Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-01-14

Clinical Trial Update: A Comparison of the Effectiveness and Safety of Injectable Risperidone With That of Risperidone Tablets in the Treatment of Patients With Chronic Schizophrenia [Phase 3]

View source ↗

Summary

Phase 3 study comparing the effectiveness and safety of injectable risperidone versus risperidone tablets in adults with chronic schizophrenia. The trial evalua…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • RISPERIDONE (RISPERIDONE)
  • Risperdal (risperidone)

Snippet

Sponsor: Janssen Pharmaceutica N.V., Belgium | Conditions: Schizophrenia, Psychotic Disorders | Phase 3 | Status: COMPLETED